group_id,Component_30,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_09826,0.6738347291264706,FUN_042659-T1,Peve_00031591,Pocillopora_meandrina_HIv1___RNAseq.g4898.t1,three_way,46.13633333333333,,,,,,,,,,,,,,,,,
OG_00531,0.6635063867153164,FUN_001545-T1,Peve_00033291,Pocillopora_meandrina_HIv1___RNAseq.g15386.t1,three_way,49.809666666666665,,,,,,,,,,,,,,,,,
OG_02532,0.6422308364552951,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_07455,0.6089776630244474,FUN_033951-T1,Peve_00032117,Pocillopora_meandrina_HIv1___RNAseq.g28360.t1,three_way,65.717,,,,,,,,,,,,,,,,,
OG_06154,0.5886204528565047,FUN_027987-T1,Peve_00023127,Pocillopora_meandrina_HIv1___RNAseq.g14022.t1,three_way,64.95433333333334,,,,,,,,,,,,,,,,,
OG_00082,0.5199643519921133,FUN_000411-T1,Peve_00010961,Pocillopora_meandrina_HIv1___RNAseq.g2317.t1,three_way,32.01166666666666,,,,,,,,,,,,,,,,,
OG_06132,0.4797981600632374,FUN_027938-T2,Peve_00032459,Pocillopora_meandrina_HIv1___RNAseq.g14030.t1,three_way,71.97066666666667,,,,,,,,,,,,,,,,,
OG_01995,0.4749491000393797,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_01486,0.4681002606936422,FUN_006162-T1,Peve_00024180,Pocillopora_meandrina_HIv1___RNAseq.g20422.t1,three_way,46.14,FUN_006162-T1,Q90827,,,,,30.2,129.0,2.5e-09,65.1,sp|Q90827|NEL_CHICK Protein NEL OS=Gallus gallus OX=9031 GN=NEL PE=2 SV=1,,,,,,
OG_07144,0.4662578976002984,FUN_032474-T1,Peve_00036450,Pocillopora_meandrina_HIv1___RNAseq.g24244.t1,three_way,56.147333333333336,,,,,,,,,,,,,,,,,
OG_07836,0.4480790226745616,FUN_035166-T1,Peve_00036194,Pocillopora_meandrina_HIv1___RNAseq.g27915.t1,three_way,52.95516666666667,FUN_035166-T1,Q29477,TRFL_CAPHI,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-),Capra hircus (Goat),35.5,366.0,2.5e-42,174.5,sp|Q29477|TRFL_CAPHI Lactotransferrin OS=Capra hircus OX=9925 GN=LTF PE=1 SV=1,GO:0001503; GO:0001817; GO:0002227; GO:0005615; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0008236; GO:0019731; GO:0019732; GO:0031665; GO:0032680; GO:0033690; GO:0042581; GO:0043066; GO:0045669; GO:0046872; GO:0055037; GO:0060349; GO:1900159; GO:1900229; GO:1902732; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; bone morphogenesis [GO:0060349]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule [GO:0042581],metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236],GO:0002376; GO:0003824; GO:0005615; GO:0005768; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; endosome; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09120,0.4469087440949118,FUN_039266-T1,Peve_00002772,Pocillopora_meandrina_HIv1___RNAseq.g13577.t1,three_way,76.14266666666667,FUN_039266-T1,P12394,,,,,43.7,462.0,3.8999999999999998e-109,396.7,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_00304,0.4365722046458452,FUN_001106-T1,Peve_00003165,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1b,three_way,75.54033333333334,,,,,,,,,,,,,,,,,
OG_08217,0.4330955218133107,FUN_036077-T1,Peve_00018989,Pocillopora_meandrina_HIv1___RNAseq.g27413.t1,three_way,66.047,,,,,,,,,,,,,,,,,
OG_00643,0.4265764818362736,FUN_001887-T1,Peve_00030489,Pocillopora_meandrina_HIv1___RNAseq.g29129.t1,three_way,64.38266666666667,FUN_001887-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),40.6,286.0,1.8000000000000002e-44,181.8,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_08098,0.4260323451594776,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_08229,0.4248752360863965,FUN_036101-T1,Peve_00032197,Pocillopora_meandrina_HIv1___RNAseq.g10817.t1,three_way,53.59666666666666,,,,,,,,,,,,,,,,,
OG_07400,0.4243307873806604,FUN_033839-T1,Peve_00016490,Pocillopora_meandrina_HIv1___RNAseq.g26367.t1,three_way,53.79466666666666,,,,,,,,,,,,,,,,,
OG_08097,0.4184926496118273,FUN_035839-T1,Peve_00032500,Pocillopora_meandrina_HIv1___RNAseq.g11958.t2,three_way,68.27866666666667,,,,,,,,,,,,,,,,,
OG_01897,0.4038488528029214,FUN_007904-T1,Peve_00040656,Pocillopora_meandrina_HIv1___RNAseq.g30059.t1,three_way,60.9685,FUN_007904-T1,P06582,,,,,37.0,100.0,1.1e-11,72.0,sp|P06582|HSP12_CAEEL Heat shock protein hsp-16.2 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.2 PE=2 SV=1,,,,,,
OG_04538,0.4034954946413524,FUN_022094-T1,Peve_00038682,Pocillopora_meandrina_HIv1___RNAseq.g4121.t1,three_way,74.00383333333333,FUN_022094-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),25.9,336.0,2.6e-20,101.7,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_00195,0.4021596826783538,FUN_000905-T1,Peve_00009733,Pocillopora_meandrina_HIv1___RNAseq.g29456.t1,three_way,66.77466666666666,FUN_000905-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),37.3,753.0,5.9e-130,466.5,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_04618,0.4019090395114282,FUN_022319-T1,Peve_00021701,Pocillopora_meandrina_HIv1___TS.g22054.t1,three_way,56.806333333333335,,,,,,,,,,,,,,,,,
OG_08151,0.4016696007869128,FUN_035923-T1,Peve_00006710,Pocillopora_meandrina_HIv1___RNAseq.g12052.t1,three_way,56.369166666666665,,,,,,,,,,,,,,,,,
OG_06663,0.4016649625395472,FUN_031054-T1,Peve_00028185,Pocillopora_meandrina_HIv1___RNAseq.g30322.t1,three_way,84.973,FUN_031054-T1,Q8CIB5,FERM2_MOUSE,,Fermitin family homolog 2 (Kindlin-2) (Pleckstrin homology domain-containing family C member 1),Mus musculus (Mouse),47.4,694.0,4.1000000000000004e-170,599.7,sp|Q8CIB5|FERM2_MOUSE Fermitin family homolog 2 OS=Mus musculus OX=10090 GN=Fermt2 PE=1 SV=1,GO:0001725; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005912; GO:0005925; GO:0005938; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009898; GO:0009986; GO:0010718; GO:0016055; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035025; GO:0043116; GO:0043539; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0070374; GO:0072657; GO:0120283; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691,"adherens junction maintenance [GO:0034334]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]",adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; I band [GO:0031674]; lamellipodium membrane [GO:0031258]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725],"actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; SMAD binding [GO:0046332]; type I transforming growth factor beta receptor binding [GO:0034713]",GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0007155; GO:0008092; GO:0008289; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,circulatory system process; nucleus; nucleoplasm; cytosol; cell adhesion; cytoskeletal protein binding; lipid binding; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_05654,0.4012077188822713,FUN_025403-T1,Peve_00026689,Pocillopora_meandrina_HIv1___RNAseq.g13308.t1,three_way,71.69633333333334,FUN_025403-T1,Q7SXN5,DNM1L_DANRE,,Dynamin-1-like protein (EC 3.6.5.5),Danio rerio (Zebrafish) (Brachydanio rerio),21.1,701.0,1.2e-07,60.1,sp|Q7SXN5|DNM1L_DANRE Dynamin-1-like protein OS=Danio rerio OX=7955 GN=dnm1l PE=2 SV=1,GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0006897; GO:0008017; GO:0008289; GO:0016020; GO:0016559; GO:0030672; GO:0042803; GO:0043653; GO:0048312; GO:0048511; GO:0051259,endocytosis [GO:0006897]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; rhythmic process [GO:0048511],clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0065003,catalytic activity; GTPase activity; mitochondrion; peroxisome; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; protein-containing complex assembly
OG_05809,0.4009491528672141,FUN_025809-T2,Peve_00017944,Pocillopora_meandrina_HIv1___TS.g19642.t2,three_way,56.2395,FUN_025809-T2,Q08EN7,,,,,29.7,286.0,1.6e-26,122.5,sp|Q08EN7|ZCPW2_MOUSE Zinc finger CW-type PWWP domain protein 2 homolog OS=Mus musculus OX=10090 GN=Zcwpw2 PE=2 SV=2,,,,,,
OG_05305,0.4004166051176885,FUN_023978-T1,Peve_00020874,Pocillopora_meandrina_HIv1___RNAseq.g19435.t1,three_way,47.72816666666667,,,,,,,,,,,,,,,,,
OG_09075,0.3997218869938689,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_04677,0.3975200371959158,FUN_022446-T1,Peve_00037587,Pocillopora_meandrina_HIv1___RNAseq.g4330.t1,three_way,71.33800000000001,FUN_022446-T1,Q29496,CP3AO_SHEEP,,Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24),Ovis aries (Sheep),38.8,485.0,1.4999999999999999e-92,341.7,sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1,GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0016712; GO:0020037; GO:0050649; GO:0070989,oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; testosterone 6-beta-hydroxylase activity [GO:0050649]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_02119,0.3969151243426566,FUN_008404-T1,Peve_00031485,Pocillopora_meandrina_HIv1___RNAseq.g18034.t1,three_way,63.198,,,,,,,,,,,,,,,,,
OG_06046,0.3956351529634825,FUN_026714-T1,Peve_00018519,Pocillopora_meandrina_HIv1___RNAseq.g9373.t1,three_way,56.48,FUN_026714-T1,Q96EW2,,,,,42.0,138.0,4.4e-20,99.4,sp|Q96EW2|HBAP1_HUMAN HSPB1-associated protein 1 OS=Homo sapiens OX=9606 GN=HSPBAP1 PE=1 SV=1,,,,,,
OG_01955,0.3947633739981558,FUN_008021-T1,Peve_00031303,Pocillopora_meandrina_HIv1___RNAseq.g30342.t1,three_way,69.569,,,,,,,,,,,,,,,,,
OG_01645,0.3942359401732925,FUN_006796-T1,Peve_00019185,Pocillopora_meandrina_HIv1___RNAseq.g20496.t1,three_way,33.34466666666667,FUN_006796-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),28.9,287.0,1.3e-17,92.4,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_00453,0.3939767819851144,FUN_001377-T1,Peve_00021886,Pocillopora_meandrina_HIv1___RNAseq.g2136.t1,three_way,56.78516666666667,,,,,,,,,,,,,,,,,
OG_01759,0.3934012862502086,FUN_007111-T1,Peve_00017835,Pocillopora_meandrina_HIv1___RNAseq.g19017.t1,three_way,39.03566666666666,,,,,,,,,,,,,,,,,
OG_06757,0.3928770581169334,FUN_031570-T1,Peve_00021507,Pocillopora_meandrina_HIv1___RNAseq.g5065.t1,three_way,57.521,FUN_031570-T1,D4A218,,,,,32.0,303.0,1.1e-26,122.5,sp|D4A218|DMRT3_RAT Doublesex and mab-3 related transcription factor 3 OS=Rattus norvegicus OX=10116 GN=Dmrt3 PE=3 SV=1,,,,,,
OG_10157,0.3904087350646645,FUN_043552-T1,Peve_00009534,Pocillopora_meandrina_HIv1___RNAseq.g8003.t1,three_way,72.05633333333333,,,,,,,,,,,,,,,,,
OG_00511,0.3903908379423508,FUN_001503-T1,Peve_00018430,Pocillopora_meandrina_HIv1___RNAseq.g1086.t1,three_way,61.830666666666666,FUN_001503-T1,P86982,,,,,41.6,137.0,3.9e-21,103.6,sp|P86982|IMSP1_RUDPH Insoluble matrix shell protein 1 (Fragment) OS=Ruditapes philippinarum OX=129788 PE=1 SV=1,,,,,,
OG_09627,0.3897431414753939,FUN_041794-T1,Peve_00009375,Pocillopora_meandrina_HIv1___RNAseq.g15767.t1,three_way,43.15016666666666,FUN_041794-T1,Q4VC17,ATS18_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-),Mus musculus (Mouse),27.2,1006.0,3.1e-77,292.0,sp|Q4VC17|ATS18_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Mus musculus OX=10090 GN=Adamts18 PE=2 SV=2,GO:0001654; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0090331,extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]; proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0030198; GO:0048856; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; extracellular matrix organization; anatomical structure development; catalytic activity, acting on a protein"
OG_05226,0.3895437670752801,FUN_023639-T1,Peve_00027828,Pocillopora_meandrina_HIv1___RNAseq.g17814.t1c,three_way,45.796,,,,,,,,,,,,,,,,,
OG_09178,0.3874644035179053,FUN_039858-T1,Peve_00020641,Pocillopora_meandrina_HIv1___RNAseq.g7287.t1a,three_way,34.05316666666667,,,,,,,,,,,,,,,,,
OG_08967,0.3873312181745937,FUN_038472-T1,Peve_00039876,Pocillopora_meandrina_HIv1___RNAseq.g28229.t1,three_way,51.10716666666666,,,,,,,,,,,,,,,,,
OG_01396,0.3846991228493825,FUN_005372-T2,Peve_00041488,Pocillopora_meandrina_HIv1___RNAseq.g6635.t1,three_way,84.41483333333333,FUN_005372-T2,P19120,HSP7C_BOVIN,,Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8),Bos taurus (Bovine),82.6,650.0,4.8e-293,1008.1,sp|P19120|HSP7C_BOVIN Heat shock cognate 71 kDa protein OS=Bos taurus OX=9913 GN=HSPA8 PE=1 SV=2,GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0016191; GO:0016887; GO:0030674; GO:0031072; GO:0042026; GO:0042470; GO:0044183; GO:0045892; GO:0051085; GO:0061740; GO:0072318; GO:0098793; GO:0140662; GO:1990904,chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; RNA splicing [GO:0008380]; synaptic vesicle uncoating [GO:0016191],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0006457; GO:0006886; GO:0016071; GO:0016787; GO:0031410; GO:0043226; GO:0044183; GO:0060090; GO:0140657,catalytic activity; nucleus; nucleolus; cytosol; plasma membrane; regulation of DNA-templated transcription; protein folding; intracellular protein transport; mRNA metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; protein folding chaperone; molecular adaptor activity; ATP-dependent activity
OG_09472,0.3844773191739334,FUN_041498-T1,Peve_00007700,Pocillopora_meandrina_HIv1___TS.g10682.t1,three_way,80.48866666666666,FUN_041498-T1,Q6Q2B2,,,,,39.5,253.0,1.1e-33,145.6,sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1,,,,,,
OG_08341,0.382081334369056,FUN_036858-T1,Peve_00001065,Pocillopora_meandrina_HIv1___RNAseq.g27061.t1,three_way,76.1845,FUN_036858-T1,P22412,,,,,50.9,369.0,1.1e-104,381.7,sp|P22412|DPEP1_PIG Dipeptidase 1 OS=Sus scrofa OX=9823 GN=DPEP1 PE=1 SV=1,,,,,,
OG_06174,0.3799244602853618,FUN_028030-T1,Peve_00044201,Pocillopora_meandrina_HIv1___RNAseq.g13933.t1,three_way,44.60566666666666,,,,,,,,,,,,,,,,,
OG_02504,0.3765750896268632,FUN_009960-T1,Peve_00007862,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1b,three_way,73.25516666666667,,,,,,,,,,,,,,,,,
OG_03327,0.3721042929243628,FUN_013418-T1,Peve_00028073,Pocillopora_meandrina_HIv1___RNAseq.g22949.t1,three_way,55.11866666666667,FUN_013418-T1,Q8X187,,,,,28.7,143.0,4e-10,67.4,sp|Q8X187|CALM_PAXIN Calmodulin OS=Paxillus involutus OX=71150 GN=calA PE=2 SV=3,,,,,,
OG_06218,0.3699228827860208,FUN_028160-T1,Peve_00000617,Pocillopora_meandrina_HIv1___RNAseq.g29828.t1,three_way,77.55183333333333,,,,,,,,,,,,,,,,,
OG_02226,0.3663635846583155,FUN_008631-T1,Peve_00012388,Pocillopora_meandrina_HIv1___RNAseq.g14912.t1,three_way,62.56166666666666,,,,,,,,,,,,,,,,,
OG_09007,0.3631167440533809,FUN_038557-T1,Peve_00020191,Pocillopora_meandrina_HIv1___RNAseq.g1024.t1,three_way,38.4565,,,,,,,,,,,,,,,,,
OG_07470,0.3608752457038969,FUN_033980-T1,Peve_00004847,Pocillopora_meandrina_HIv1___RNAseq.g26110.t1,three_way,64.06066666666666,FUN_033980-T1,Q1EHB4,SC5AC_HUMAN,,Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12),Homo sapiens (Human),34.5,560.0,3.3e-86,320.9,sp|Q1EHB4|SC5AC_HUMAN Sodium-coupled monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC5A12 PE=1 SV=2,GO:0005343; GO:0005654; GO:0005886; GO:0006811; GO:0006814; GO:0015129; GO:0015293; GO:0015718; GO:0016324; GO:0070062; GO:0140161,monoatomic ion transport [GO:0006811]; monocarboxylic acid transport [GO:0015718]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; symporter activity [GO:0015293],GO:0005215; GO:0005654; GO:0005886; GO:0043226,transporter activity; nucleoplasm; plasma membrane; organelle
OG_09894,0.3585709850701873,FUN_042988-T1,Peve_00036062,Pocillopora_meandrina_HIv1___RNAseq.g7093.t1,three_way,53.70933333333333,,,,,,,,,,,,,,,,,
OG_04508,0.3561471846357538,FUN_022036-T1,Peve_00019003,Pocillopora_meandrina_HIv1___RNAseq.g9285.t1,three_way,61.077333333333335,,,,,,,,,,,,,,,,,
OG_00246,0.3548013301647758,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_04651,0.3539237746104204,FUN_022386-T3,Peve_00037603,Pocillopora_meandrina_HIv1___RNAseq.g9310.t1,three_way,63.92666666666666,FUN_022386-T3,B8V7S0,,,,,48.6,251.0,2.8e-62,241.5,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_03869,0.353360804895403,FUN_015381-T1,Peve_00000227,Pocillopora_meandrina_HIv1___TS.g26436.t1,three_way,62.752,,,,,,,,,,,,,,,,,
OG_06554,0.3533436253331837,FUN_029431-T1,Peve_00039461,Pocillopora_meandrina_HIv1___RNAseq.g17172.t1,three_way,70.55433333333333,,,,,,,,,,,,,,,,,
OG_05826,0.3532817281384811,FUN_025843-T1,Peve_00028316,Pocillopora_meandrina_HIv1___RNAseq.g10339.t1,three_way,66.52566666666667,,,,,,,,,,,,,,,,,
OG_00258,0.3511728116320229,FUN_001025-T1,Peve_00041055,Pocillopora_meandrina_HIv1___RNAseq.g16888.t1,three_way,40.96733333333333,,,,,,,,,,,,,,,,,
OG_09091,0.3507983177108565,FUN_038889-T1,Peve_00028699,Pocillopora_meandrina_HIv1___RNAseq.g28663.t1,three_way,51.704,,,,,,,,,,,,,,,,,
OG_04693,0.3477318777254361,FUN_022485-T1,Peve_00002925,Pocillopora_meandrina_HIv1___RNAseq.g4293.t1,three_way,88.12733333333333,,,,,,,,,,,,,,,,,
OG_05506,0.3432667729445993,FUN_024587-T1,Peve_00037917,Pocillopora_meandrina_HIv1___RNAseq.2717_t,three_way,63.268,,,,,,,,,,,,,,,,,
OG_05674,0.3431551577083648,FUN_025504-T1,Peve_00040926,Pocillopora_meandrina_HIv1___RNAseq.g13217.t1,three_way,54.756166666666665,FUN_025504-T1,Q90X46,GP161_DANRE,,G-protein coupled receptor 161,Danio rerio (Zebrafish) (Brachydanio rerio),42.3,196.0,3.5e-33,144.8,sp|Q90X46|GP161_DANRE G-protein coupled receptor 161 OS=Danio rerio OX=7955 GN=gpr161 PE=2 SV=2,GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0007368; GO:0051924; GO:0055037; GO:0060170; GO:1901621,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; determination of left/right symmetry [GO:0007368]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; regulation of calcium ion transport [GO:0051924],ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037],G protein-coupled receptor activity [GO:0004930],GO:0005768; GO:0005929; GO:0031410; GO:0043226; GO:0060089,endosome; cilium; cytoplasmic vesicle; organelle; molecular transducer activity
OG_02791,0.3411270989768827,FUN_011747-T1,Peve_00034099,Pocillopora_meandrina_HIv1___RNAseq.9509_t,three_way,56.78566666666666,FUN_011747-T1,C5H5C4,NOT1A_DANRE,,Palmitoleoyl-protein carboxylesterase notum1a (EC 3.1.1.98),Danio rerio (Zebrafish) (Brachydanio rerio),40.0,417.0,7.7e-82,305.8,sp|C5H5C4|NOT1A_DANRE Palmitoleoyl-protein carboxylesterase notum1a OS=Danio rerio OX=7955 GN=notum1a PE=2 SV=1,GO:0004621; GO:0005576; GO:0009952; GO:0016055; GO:0021532; GO:0030178; GO:0090090; GO:1990697; GO:1990699,anterior/posterior pattern specification [GO:0009952]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055],extracellular region [GO:0005576],glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005576; GO:0016787; GO:0030163,catalytic activity; extracellular region; hydrolase activity; protein catabolic process
OG_03171,0.3367701546465149,FUN_012594-T1,Peve_00042400,Pocillopora_meandrina_HIv1___RNAseq.g13631.t1,three_way,63.02033333333333,FUN_012594-T1,Q91YI6,GLD2_MOUSE,,Poly(A) RNA polymerase GLD2 (mGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4) (Terminal nucleotidyltransferase 2),Mus musculus (Mouse),35.1,328.0,2.3e-38,161.0,sp|Q91YI6|GLD2_MOUSE Poly(A) RNA polymerase GLD2 OS=Mus musculus OX=10090 GN=Tent2 PE=1 SV=1,GO:0002244; GO:0005524; GO:0005634; GO:0005737; GO:0031124; GO:0046872; GO:0071044; GO:0140958; GO:1990817; GO:2000626,hematopoietic progenitor cell differentiation [GO:0002244]; histone mRNA catabolic process [GO:0071044]; mRNA 3'-end processing [GO:0031124]; negative regulation of miRNA catabolic process [GO:2000626]; target-directed miRNA degradation [GO:0140958],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003824; GO:0005634; GO:0016071; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nucleus; mRNA metabolic process; transferase activity; cell differentiation; organelle
OG_07414,0.336457555396766,FUN_033872-T1,Peve_00043319,Pocillopora_meandrina_HIv1___RNAseq.g28409.t1,three_way,53.156,,,,,,,,,,,,,,,,,
OG_02942,0.3352796777603049,FUN_012054-T3,Peve_00004085,Pocillopora_meandrina_HIv1___RNAseq.g23646.t1,three_way,73.15266666666666,FUN_012054-T3,Q7Z020,,,,,22.2,504.0,9.3e-26,120.9,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_01642,0.3349607841139736,FUN_006790-T1,Peve_00028070,Pocillopora_meandrina_HIv1___RNAseq.g20501.t1,three_way,54.868,FUN_006790-T1,P35918,,,,,31.5,961.0,9.8e-99,363.6,sp|P35918|VGFR2_MOUSE Vascular endothelial growth factor receptor 2 OS=Mus musculus OX=10090 GN=Kdr PE=1 SV=2,,,,,,
OG_07872,0.3349552374339726,FUN_035231-T1,Peve_00044486,Pocillopora_meandrina_HIv1___RNAseq.g27905.t1,three_way,73.57433333333333,,,,,,,,,,,,,,,,,
OG_02998,0.3331426308897642,FUN_012177-T1,Peve_00040996,Pocillopora_meandrina_HIv1___RNAseq.g23859.t1,three_way,91.90766666666669,FUN_012177-T1,P18654,KS6A3_MOUSE,,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),Mus musculus (Mouse),67.4,742.0,1e-291,1003.8,sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2,GO:0000287; GO:0002224; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0019901; GO:0032496; GO:0035556; GO:0043066; GO:0045944; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06842,0.33228536553383,FUN_031782-T1,Peve_00010427,Pocillopora_meandrina_HIv1___RNAseq.g5565.t1,three_way,65.31783333333333,FUN_031782-T1,P29176,,,,,44.2,77.0,1.2e-06,55.1,sp|P29176|FOSX_MSVFR Transforming protein v-Fos/v-Fox OS=FBR murine osteosarcoma virus OX=353765 GN=FOS-FOX PE=3 SV=1,,,,,,
OG_03070,0.3272113993785889,FUN_012340-T1,Peve_00042542,Pocillopora_meandrina_HIv1___RNAseq.g23343.t1,three_way,61.76633333333333,FUN_012340-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),30.7,205.0,2.5e-17,91.7,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_09204,0.3265528999802317,FUN_039892-T1,Peve_00021860,Pocillopora_meandrina_HIv1___RNAseq.g7364.t1,three_way,45.9685,FUN_039892-T1,Q9JK41,COPT1_RAT,,High affinity copper uptake protein 1 (Copper transporter 1) (rCTR1) (Liver regeneration-related protein LRRGT00200) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form],Rattus norvegicus (Rat),31.9,144.0,2e-09,64.3,sp|Q9JK41|COPT1_RAT High affinity copper uptake protein 1 OS=Rattus norvegicus OX=10116 GN=Slc31a1 PE=2 SV=1,GO:0001525; GO:0005375; GO:0005507; GO:0005770; GO:0005886; GO:0006825; GO:0006878; GO:0014704; GO:0015080; GO:0015677; GO:0015679; GO:0016323; GO:0016324; GO:0031901; GO:0031902; GO:0036324; GO:0042802; GO:0042908; GO:0042910; GO:0043025; GO:0051259; GO:0051649; GO:0055037; GO:0055038; GO:0055085; GO:0072719; GO:0098705; GO:1902601,angiogenesis [GO:0001525]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; plasma membrane copper ion transport [GO:0015679]; protein complex oligomerization [GO:0051259]; silver ion transmembrane transport [GO:1902601]; transmembrane transport [GO:0055085]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; xenobiotic transport [GO:0042908],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; intercalated disc [GO:0014704]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; silver ion transmembrane transporter activity [GO:0015080]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085; GO:0065003,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport; protein-containing complex assembly
OG_08228,0.3265299672916285,FUN_036100-T1,Peve_00032196,Pocillopora_meandrina_HIv1___RNAseq.g27435.t1,three_way,77.412,FUN_036100-T1,Q0P8I7,GMHD_CAMJE,,GDP-D-glycero-alpha-D-manno-heptose dehydrogenase (EC 1.1.98.-),Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168),41.3,310.0,2.6e-64,247.3,sp|Q0P8I7|GMHD_CAMJE GDP-D-glycero-alpha-D-manno-heptose dehydrogenase OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) OX=192222 GN=Cj1427c PE=1 SV=1,GO:0003978; GO:0016491; GO:0019003; GO:0042802; GO:0045227; GO:0051289; GO:0070404,capsule polysaccharide biosynthetic process [GO:0045227]; protein homotetramerization [GO:0051289],,GDP binding [GO:0019003]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; oxidoreductase activity [GO:0016491]; UDP-glucose 4-epimerase activity [GO:0003978],GO:0003824; GO:0005975; GO:0016491; GO:0016853; GO:0065003,catalytic activity; carbohydrate metabolic process; oxidoreductase activity; isomerase activity; protein-containing complex assembly
OG_05371,0.3259169611098035,FUN_024173-T1,Peve_00010869,Pocillopora_meandrina_HIv1___RNAseq.g13457.t1,three_way,74.04,FUN_024173-T1,Q2UPB1,,,,,24.9,454.0,1.8e-29,132.1,sp|Q2UPB1|ACLC_ASPOR Cytochrome P450 monooxygenase aclC OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) OX=510516 GN=aclC PE=3 SV=1,,,,,,
OG_02728,0.325829604668114,FUN_011252-T1,Peve_00024318,Pocillopora_meandrina_HIv1___RNAseq.g11307.t1,three_way,52.192,,,,,,,,,,,,,,,,,
OG_01250,0.3247691915734885,FUN_004969-T1,Peve_00043270,Pocillopora_meandrina_HIv1___TS.g20136.t1,three_way,49.14716666666666,,,,,,,,,,,,,,,,,
OG_05192,0.3246545001273889,FUN_023558-T1,Peve_00037258,Pocillopora_meandrina_HIv1___RNAseq.g519.t1,three_way,71.653,FUN_023558-T1,P29419,,,,,46.3,67.0,8.1e-07,53.9,"sp|P29419|ATP5I_RAT ATP synthase F(0) complex subunit e, mitochondrial OS=Rattus norvegicus OX=10116 GN=Atp5me PE=1 SV=3",,,,,,
OG_07118,0.3245874962705048,FUN_032395-T1,Peve_00036447,Pocillopora_meandrina_HIv1___RNAseq.g29833.t1,three_way,64.09349999999999,FUN_032395-T1,Q76LC6,RBM24_DANRE,,RNA-binding protein 24 (RNA-binding motif protein 24) (RNA-binding protein SEB-4),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,89.0,7.2e-27,122.5,sp|Q76LC6|RBM24_DANRE RNA-binding protein 24 OS=Danio rerio OX=7955 GN=rbm24 PE=2 SV=1,GO:0000381; GO:0001654; GO:0001756; GO:0001947; GO:0003228; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006974; GO:0007519; GO:0008380; GO:0010830; GO:0010831; GO:0035315; GO:0035925; GO:0043488; GO:0045663; GO:0048255; GO:0048702; GO:0060297; GO:0060298; GO:0061157; GO:0061158; GO:0071599; GO:0072359; GO:0097157; GO:1902811; GO:1905870; GO:1990715; GO:1990825; GO:2000738; GO:2000766,"3'-UTR-mediated mRNA destabilization [GO:0061158]; atrial cardiac muscle tissue development [GO:0003228]; circulatory system development [GO:0072359]; DNA damage response [GO:0006974]; embryonic neurocranium morphogenesis [GO:0048702]; eye development [GO:0001654]; hair cell differentiation [GO:0035315]; heart looping [GO:0001947]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; otic vesicle development [GO:0071599]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of skeletal muscle fiber differentiation [GO:1902811]; positive regulation of stem cell differentiation [GO:2000738]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA stability [GO:0043488]; regulation of myotube differentiation [GO:0010830]; regulation of sarcomere organization [GO:0060297]; RNA splicing [GO:0008380]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0030154; GO:0043226; GO:0048856,RNA binding; nucleus; cytosol; mRNA metabolic process; cell differentiation; organelle; anatomical structure development
OG_02927,0.3232526318864008,FUN_012020-T1,Peve_00030377,Pocillopora_meandrina_HIv1___RNAseq.g24050.t1,three_way,58.77833333333333,FUN_012020-T1,Q5UAW9,GP157_HUMAN,,G-protein coupled receptor 157,Homo sapiens (Human),34.6,289.0,1.7e-39,164.9,sp|Q5UAW9|GP157_HUMAN G-protein coupled receptor 157 OS=Homo sapiens OX=9606 GN=GPR157 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0007200; GO:0048512; GO:0060019; GO:0060170,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; radial glial cell differentiation [GO:0060019],ciliary membrane [GO:0060170]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0030154; GO:0060089,plasma membrane; cell differentiation; molecular transducer activity
OG_05351,0.3220015918969211,FUN_024121-T1,Peve_00000177,Pocillopora_meandrina_HIv1___RNAseq.g19176.t1,three_way,46.95433333333333,,,,,,,,,,,,,,,,,
OG_00144,0.3219138689720293,FUN_000586-T1,Peve_00025314,Pocillopora_meandrina_HIv1___TS.g6498.t2,three_way,63.92666666666666,FUN_000586-T1,O00339,MATN2_HUMAN,,Matrilin-2,Homo sapiens (Human),30.2,192.0,2.3e-14,82.4,sp|O00339|MATN2_HUMAN Matrilin-2 OS=Homo sapiens OX=9606 GN=MATN2 PE=1 SV=4,GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216,axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0048870,structural molecule activity; extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; cell motility
OG_08355,0.3196564880033608,FUN_036899-T1,Peve_00018371,Pocillopora_meandrina_HIv1___RNAseq.g26703.t1,three_way,78.23133333333332,FUN_036899-T1,Q8VZ42,,,,,40.3,129.0,1.3e-25,117.5,sp|Q8VZ42|SAP11_ARATH Zinc finger AN1 and C2H2 domain-containing stress-associated protein 11 OS=Arabidopsis thaliana OX=3702 GN=SAP11 PE=2 SV=1,,,,,,
OG_05573,0.319381407045088,FUN_024861-T1,Peve_00026074,Pocillopora_meandrina_HIv1___RNAseq.g18770.t1,three_way,57.13,FUN_024861-T1,Q8NEG2,,,,,29.7,182.0,2.8e-08,60.8,sp|Q8NEG2|CG057_HUMAN Uncharacterized protein C7orf57 OS=Homo sapiens OX=9606 GN=C7orf57 PE=1 SV=3,,,,,,
OG_04219,0.3184511314347683,FUN_016970-T1,Peve_00025293,Pocillopora_meandrina_HIv1___RNAseq.g9903.t2,three_way,56.20816666666666,,,,,,,,,,,,,,,,,
OG_04609,0.3175196862846388,FUN_022305-T1,Peve_00003816,Pocillopora_meandrina_HIv1___RNAseq.g3971.t1,three_way,36.00233333333333,,,,,,,,,,,,,,,,,
OG_02325,0.3172738663924774,FUN_008917-T1,Peve_00033005,Pocillopora_meandrina_HIv1___RNAseq.g3982.t1,three_way,74.89333333333333,FUN_008917-T1,Q6V5K9,,,,,46.8,269.0,1e-59,232.6,sp|Q6V5K9|ZN474_MOUSE Zinc finger protein 474 OS=Mus musculus OX=10090 GN=Znf474 PE=2 SV=2,,,,,,
OG_02828,0.3163077906169975,FUN_011843-T1,Peve_00034373,Pocillopora_meandrina_HIv1___RNAseq.g23373.t1,three_way,84.43299999999999,FUN_011843-T1,Q9SEE4,,,,,41.8,297.0,9.3e-61,235.3,sp|Q9SEE4|PIRL_SOLLC Pirin-like protein OS=Solanum lycopersicum OX=4081 PE=2 SV=1,,,,,,
OG_06553,0.315336470587583,FUN_029428-T1,Peve_00039462,Pocillopora_meandrina_HIv1___RNAseq.g17173.t1,three_way,68.539,,,,,,,,,,,,,,,,,
OG_00314,0.3145814541887747,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_07933,0.3137733684992079,FUN_035426-T1,Peve_00007639,Pocillopora_meandrina_HIv1___RNAseq.g27573.t1,three_way,42.896,,,,,,,,,,,,,,,,,
OG_00957,0.3136984648636713,FUN_004321-T1,Peve_00016506,Pocillopora_meandrina_HIv1___RNAseq.g11786.t1,three_way,75.91266666666667,FUN_004321-T1,P54357,,,,,42.0,143.0,3.7e-23,109.4,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_09443,0.3111003121709744,FUN_041432-T2,Peve_00027845,Pocillopora_meandrina_HIv1___RNAseq.g15740.t1,three_way,86.71633333333334,FUN_041432-T2,Q90837,,,,,41.4,459.0,1.8000000000000002e-81,304.7,sp|Q90837|ERG_CHICK Transcriptional regulator Erg OS=Gallus gallus OX=9031 GN=ERG PE=2 SV=1,,,,,,
OG_08923,0.3096436216964076,FUN_038380-T1,Peve_00000073,Pocillopora_meandrina_HIv1___RNAseq.g1059.t1,three_way,73.2775,FUN_038380-T1,Q8VCC8,RPGF3_MOUSE,,Rap guanine nucleotide exchange factor 3 (Exchange factor directly activated by cAMP 1) (Exchange protein directly activated by cAMP 1) (EPAC 1) (cAMP-regulated guanine nucleotide exchange factor I) (cAMP-GEFI),Mus musculus (Mouse),32.5,123.0,8.6e-08,60.8,sp|Q8VCC8|RPGF3_MOUSE Rap guanine nucleotide exchange factor 3 OS=Mus musculus OX=10090 GN=Rapgef3 PE=1 SV=2,GO:0001525; GO:0005085; GO:0005886; GO:0005902; GO:0008306; GO:0019904; GO:0030027; GO:0030175; GO:0030552; GO:0030864; GO:0032486; GO:0032956; GO:0034242; GO:0043547; GO:0045766; GO:0046827; GO:0051496; GO:0051896; GO:0060143; GO:0061028; GO:0071320,angiogenesis [GO:0001525]; associative learning [GO:0008306]; cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; negative regulation of syncytium formation by plasma membrane fusion [GO:0034242]; positive regulation of angiogenesis [GO:0045766]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of syncytium formation by plasma membrane fusion [GO:0060143]; Rap protein signal transduction [GO:0032486]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896],cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886],cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904],GO:0005856; GO:0005886; GO:0043226; GO:0048856; GO:0050877; GO:0098772,cytoskeleton; plasma membrane; organelle; anatomical structure development; nervous system process; molecular function regulator activity
OG_08094,0.3087071963705322,FUN_035829-T1,Peve_00002595,Pocillopora_meandrina_HIv1___RNAseq.g11938.t1,three_way,39.348333333333336,,,,,,,,,,,,,,,,,
OG_09146,0.3076392386187914,FUN_039798-T1,Peve_00017577,Pocillopora_meandrina_HIv1___RNAseq.g7474.t1,three_way,69.27600000000001,,,,,,,,,,,,,,,,,
OG_06998,0.3058748379144616,FUN_032147-T1,Peve_00007908,Pocillopora_meandrina_HIv1___RNAseq.g5342.t1,three_way,65.17866666666666,FUN_032147-T1,Q3U435,MMP25_MOUSE,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-),Mus musculus (Mouse),37.3,566.0,7.6e-77,289.7,sp|Q3U435|MMP25_MOUSE Matrix metalloproteinase-25 OS=Mus musculus OX=10090 GN=Mmp25 PE=2 SV=1,GO:0004222; GO:0005886; GO:0006508; GO:0008270; GO:0009986; GO:0016504; GO:0031012; GO:0060022; GO:0098552,hard palate development [GO:0060022]; proteolysis [GO:0006508],cell surface [GO:0009986]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],metalloendopeptidase activity [GO:0004222]; peptidase activator activity [GO:0016504]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016787; GO:0030312; GO:0031012; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; external encapsulating structure; extracellular matrix; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_10176,0.3057735139203527,FUN_043585-T1,Peve_00045227,Pocillopora_meandrina_HIv1___RNAseq.g6986.t1,three_way,56.91216666666666,FUN_043585-T1,Q9BYX4,IFIH1_HUMAN,,Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116),Homo sapiens (Human),27.6,1184.0,1.0000000000000001e-88,330.1,sp|Q9BYX4|IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IFIH1 PE=1 SV=3,GO:0002753; GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016887; GO:0016925; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0034344; GO:0038187; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051259; GO:0051607; GO:0060337; GO:0060760; GO:0071360; GO:0098586; GO:0140374,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0065003; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; hydrolase activity; isomerase activity; organelle; molecular transducer activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
